HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents.

Abstract
The anxiolytic potential of the selective sigma2 ligand 1-[4-[1-(4-Fluorophenyl)-1H-indol-3-yl]-1-butyl]spiro[isobenzofuran-1(3H),4-piperidine] [corrected] (Lu 28-179) was assessed in various animal models of anxiety in rodents. Lu 28-179 facilitated the exploratory behavior of mice and rats in the black and white two-compartment box over a large dose range. In the rat, the minimal effective dose (MED) was 0.18 nmol/kg (0.1 microg/kg), and in the mouse, the MED was 0.00018 nmol/kg (0.1 ng/kg). The anxiolytic-like effect was maintained after treatment with 1 microg/kg/day for up to 14 days, and no anxiogenic-like effects were seen upon withdrawal from repeated treatment. Lu 28-179 increased the time that pairs of rats spent in active social interaction (unfamiliar high-light conditions), MED = 0.1 ng/kg. Daily treatment with Lu 28-179 (1.8 nmol/kg = 1 microg/kg/day) for up to 4 weeks increased the social interaction time significantly compared with controls, and no anxiogenic-like effects were seen upon withdrawal. Furthermore, Lu 28-179 reversed shock-induced suppression of drinking in the rat (MED = 18,000 nmol/kg = 10 mg/kg). Lu 28-179 did not inhibit footshock-induced ultrasonic vocalization in the rat or isolation-induced aggressive behavior in the mouse. Lu 28-179 was over 100 times more potent than diazepam in the rat and mouse black and white test box and the rat social interaction test, whereas the potency of Lu 28-179 was comparable to that of lorazepam in reversal of shock-induced suppression of drinking. Lu 28-179 neither induced sedation nor impaired motor coordination, even at high doses (70,000 nmol/kg = 40 mg/kg). In conclusion, Lu 28-179 exerts potent and long-lasting anxiolytic-like effects in rodents without inducing sedation and withdrawal anxiogenesis.
AuthorsC Sánchez, J Arnt, B Costall, M E Kelly, E Meier, R J Naylor, J Perregaard
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 283 Issue 3 Pg. 1323-32 (Dec 1997) ISSN: 0022-3565 [Print] United States
PMID9400007 (Publication Type: Journal Article)
Chemical References
  • Anti-Anxiety Agents
  • Indoles
  • Lu 28-179
  • Receptors, sigma
  • Spiro Compounds
Topics
  • Animals
  • Anti-Anxiety Agents (pharmacology)
  • Dose-Response Relationship, Drug
  • Indoles (metabolism, pharmacology)
  • Male
  • Mice
  • Motor Activity (drug effects)
  • Rats
  • Rats, Wistar
  • Receptors, sigma (drug effects, metabolism)
  • Spiro Compounds (metabolism, pharmacology)
  • Vocalization, Animal (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: